Results 11 to 20 of about 418,008 (279)

Engineering Micro–Nanomaterials for Biomedical Translation [PDF]

open access: yesAdvanced NanoBiomed Research, 2021
Engineered nano–bio interfaces–driven by vertical micro/nanoneedles, nanoparticles, organ‐on‐chip devices, and a diversity of nanosubstrates for mass spectroscopy imaging–are spurring scientific and technological progress, from fundamental to ...
Yaping Chen   +8 more
doaj   +2 more sources

Nanoparticles for Biomedical Imaging: Fundamentals of Clinical Translation

open access: yesMolecular Imaging, 2010
Because of their large size compared to small molecules and their multifunctionality, nanoparticles (NPs) hold promise as biomedical imaging, diagnostic, and theragnostic agents.
Hak Soo Choi, John V. Frangioni
doaj   +3 more sources

IXA Biomedical Translation System at WMT16 Biomedical Translation Task [PDF]

open access: yesProceedings of the First Conference on Machine Translation: Volume 2, Shared Task Papers, 2016
In this paper we present the system developed at the IXA NLP Group of the University of the Basque Country for the Biomedical Translation Task in the First Conference on Machine Translation (WMT16). For the adaptation of a statistical machine translation system to the biomedical domain, we developed three approaches based on a baseline system for ...
Olatz Perez-de-Viñaspre, Gorka Labaka
openaire   +1 more source

Translating translation: Regulated protein translation as a biomedical intervention [PDF]

open access: yesFly, 2009
Altering the cellular response to internal and external stressors is essential for survival, hence the process of translation is exquisitely regulated to rapidly change the proteomic profile upon physiological challenges. We recently reported that genetic and pharmacological manipulation of translation may be beneficial in the treatment of Parkinson ...
Luke S, Tain, Alexander J, Whitworth
openaire   +2 more sources

Toward A Universal Biomedical Data Translator [PDF]

open access: yesClinical and Translational Science, 2018
Myriad biomedical data are available today and bring with them a need to "translate" those data into meaningful information that can be used to accelerate clinical and translational science and drive innovations in clinical care and drug discovery. We describe the work of The Biomedical Data Translator Consortium to develop a platform that supports the
Fecho, Karamarie   +22 more
openaire   +4 more sources

Progress toward a universal biomedical data translator

open access: yesClinical and Translational Science, 2022
AbstractClinical, biomedical, and translational science has reached an inflection point in the breadth and diversity of available data and the potential impact of such data to improve human health and well‐being. However, the data are often siloed, disorganized, and not broadly accessible due to discipline‐specific differences in terminology and ...
Fecho, Karamarie   +178 more
openaire   +5 more sources

Optimization and Improvement of qPCR Detection Sensitivity of SARS-CoV-2 in Saliva

open access: yesMicrobiology Spectrum, 2023
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a major public health threat globally, especially during the beginning of the pandemic in 2020.
Hui-Ying Ko   +8 more
doaj   +1 more source

Understanding the role of APOE Gene Polymorphisms in Minimal Atrophy Alzheimer’s Disease by mixture of expert models [PDF]

open access: yesE3S Web of Conferences, 2021
Alzheimer’s disease (AD) is a heterogeneous disease. Exploring the characteristics of each AD subtype is the key to disentangling the heterogeneity. Minimal atrophy AD (MAD) is a common AD subtype that yields conflicting results.
Lin Lan   +3 more
doaj   +1 more source

Switching from blonanserin tablets to blonanserin transdermal patches improves tardive dyskinesia: A case report

open access: yesNeuropsychopharmacology Reports, 2021
Tardive dyskinesia (TD) is a common side effect of antipsychotics, and it remains a persistent and challenging problem. The blonanserin transdermal patch, developed in Japan and launched in September 2019, is the first antipsychotic transdermal treatment.
Shintaro Sakai   +6 more
doaj   +1 more source

Is preclinical research in cancer biology reproducible enough?

open access: yeseLife, 2021
The Reproducibility Project: Cancer Biology (RPCB) was established to provide evidence about reproducibility in basic and preclinical cancer research, and to identify the factors that influence reproducibility more generally.
Patrick Bodilly Kane, Jonathan Kimmelman
doaj   +1 more source

Home - About - Disclaimer - Privacy